Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As OneIUSDF 93 Debt-to-Equity is 0.07 as of Mar. 2026, which is 17% above its 10-year median of 0.06. GuruFocus rates IUSDF with a GF Score™ of 93/100 and a GF Value™ of $17.45. The stock has 2 warning signs investors should review. Among 97 Medical Distribution companies, As One ranks better than 84.54% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for As One's Debt-to-Equity or its related term are showing as below:
IUSDF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.06 Max: 0.11
Current: 0.07
During the past 13 years, the highest Debt-to-Equity Ratio of As One was 0.11. The lowest was 0.04. And the median was 0.06.
IUSDF's Debt-to-Equity is ranked better than 84.54% of 97
companies
in the Medical Distribution industry
Industry Median: 0.48
vs IUSDF: 0.07
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
As One Debt-to-Equity Related Terms
As One Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for As One's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, As One's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
As One Debt-to-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, As One's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where As One's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
As One (IUSDF) has a Debt-to-Equity of 0.07 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on As One and its competitors. This is 17% above median its historical median of 0.06. Over the past decade, As One's Debt-to-Equity has ranged from 0.04 to 0.11. According to the industry distribution chart, As One ranks #15 out of 97 companies in the Medical Distribution industry, placing it in the top 15.5%.
Is As One's Debt-to-Equity too high?
As One's current Debt-to-Equity of 0.07 is 17% above median its 10-year median of 0.06. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.11. The Medical Distribution industry median Debt-to-Equity is 0.48. As One's value of 0.07 is 85.4% below this industry median. Based on the distribution chart, As One ranks #15 out of 97 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, As One has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does As One's Debt-to-Equity compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, As One ranks #15 out of 97 companies for Debt-to-Equity. This places As One in the top 16% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.48. As One's value of 0.07 is 85.4% below this benchmark. Historically, As One's own Debt-to-Equity has ranged from 0.04 to 0.11 over the past decade. While the company's 10-year median is 0.06 vs. the industry median of 0.48, As One has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Distribution company?
The median Debt-to-Equity among Medical Distribution companies is 0.48, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. As One's current Debt-to-Equity of 0.07 is 85.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on As One and its competitors. For the Medical Distribution industry, the median Debt-to-Equity is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. As One's current Debt-to-Equity is 0.07, which is 17% above median its own 10-year median of 0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is As One stock overvalued right now?
As One (IUSDF) has a current Debt-to-Equity of 0.07. The stock's GF Value™ is $17.45, compared to a current price of $14.00 — trading 19.8% below its estimated fair value. The current Debt-to-Equity is 0.07, which is 17% above median its 10-year median of 0.06 and 85.4% below the Medical Distribution industry median of 0.48. As One's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For As One (IUSDF), the current Debt-to-Equity is 0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is As One (IUSDF) Overvalued in 2026?
Based on GuruFocus' analysis, As One stock appears to be undervalued.
The current stock price of $14.00 is trading 19.8% below its estimated GF Value™ of $17.45.
Key valuation signals for IUSDF:
Debt-to-Equity: 0.07 (17% above median its 10-year median of 0.06)
GF Value™: $17.45 vs. price of $14.00 (19.8% below fair value)
Industry Position: 85.4% below the Medical Distribution median (#15 of 97)
No single metric tells the full story. See the IUSDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
As One Corp is a trading engaged in sale of scientific instruments, industrial instruments, hospital or nursing instruments and approach to specialized fields. The company generates maximum revenue from scientific instrument product line which includes measuring instruments; cultivation, separation, analysis products such as microscopes, glass slides, and tissue culture products; Equipment / storage / conveyance products such as experimental platforms, fume hoods; Vessels or containers which includes storage of samples, reagents; Necessities for experiments including glass or plastic beakers, flask indispensable for experiments, hoses, tubes, joints, plus paper products such as tapes and labels; Equipment for laboratories like timers, packaging machines, tools, office supplies.
93GF Score
Get the complete analysis for IUSDF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IUSDF has been successfully added to your 
